semaglutide alzheimer phase 3 Medscape | Topline results from the EVOKE and EVOKE+ studies of oral in early Alzheimer's disease (AD) show that the trials did Semaglutide's Alzheimer's Trial Failure: Rethinking

We are not just about surface-level enhancements

At Unicity, our goal isn't to fight against your body's natural biologyit's to help support it

Approved compounds like semaglutide require a prescription

There are currently around 54 million patients with a diagnosis of dementia worldwide with incidence rates predicted to triple internationally to 152 million people by 2050 and will cost health services $2 trillion a year by 2030 as per the World Alzheimer Report 2018 [3]

The Molecular Profile of BPC-157 BPC-157 is a synthetic pentadecapeptide composed of 15 amino acids derived from a naturally occurring protective partial sequence isolated from human gastric juice protein 1

Yes, but introduce new products slowly to avoid overwhelming your skin